FDA says that the GLP-1 shortage is over
US$ 23.79
semaglutide ckd approval Poll: Do you think we'll see new FDA for semaglutide, specifically or Heart Failure and/or CKD, in 2025? π This post highlights primary takeaways from 2 major trials from the past ~ Effects of Semaglutide on CKD
Description
Both peptides can help individuals achieve weight loss goals when used following a prudent dosing schedule
No Canadian has faced prosecution for possessing or using research peptides for personal purposes
Self-Pay Program Options: Monthly Program: from $279 10-Week Program (2.5 months): from $449 20-Week Program (5 months): from $749 Dosage, pricing, and medication details vary based on medical evaluation and clinical need
JAMA 327 , 24232433 (2022)
While some patents expire in 2026, many others protecting the drug's delivery system and methods of use extend well beyond, likely until 2033 or later
People with a personal or family history of certain thyroid conditions should discuss risks with their doctor before beginning
